An interventional study of EIM+ in Physical Inactivity and Obesity, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Ohio State University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.
Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 147th largest by enrollment of the 421 interventional ones that give a count, is one of 39 that started in 2024, is one of 386 with no phase, and was the 380th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:
St. Louis University · Sites in United States
Ages 18–69
University of Pittsburgh · Sites in United States
Ages 14–26
University of Wisconsin, River Falls · Sites in United States
Ages 18–60 · Healthy volunteers
The University of Tennessee, Knoxville · Sites in United States
Ages 65+
San Diego State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
452 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 19 · Phase 2 15 · Phase 3 3 · Phase 4 2
First in 2000; this study’s year is marked. 39 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 85 is above the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 60 across the 421 interventional studies, 122 across the 30 observational. Of the 335 that completed or were terminated, 105 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 452 have an industry lead sponsor. The 10 most frequent:
Ohio State University is the lead sponsor of 664 studies on the registry; 149 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 49 (73%) have results posted.
Ohio State University has 5 studies filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
40 of the studies in Sedentary Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT06923397Dana-Farber Cancer InstituteInterrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | 2026-11-28 |
| NCT06116435University of Colorado, DenverA Pilot Factorial Trial of an Integrated Lifestyle Intervention | 2026-12 |
| NCT06754280University of Illinois at ChicagoAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease | 2026-12 |
| NCT07270016University of PittsburghPilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes | 2026-12 |
Add all 40 to your calendar (.ics) → With an account.
Among the 452 studies in Sedentary Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The effects of exercise on prevention and improved control of chronic diseases, reduced mortality, and improved quality of life are well established. Exercise has been shown to prevent heart disease, stroke, type 2 diabetes, depression, and certain types of cancers. In addition to prevention, physical activity is included in the standard or care for many chronic diseases and used in treatment. For example, the American Diabetes Association has identified positive health behaviors like physical activity as foundational in the treatment and management of disease and improving overall quality of life.
The Ohio State University Wexner Medical Center Exercise is Medicine Program (EIM) is a physician referral program that aims to increase physical activity to prevent and reduce complications from chronic disease.
The integration of technology among a 65+ population of EIM participants provides a novel approach to improving individual's health. Thus, our study aims to provide EIM participants aged 65+ with smartwatches in the hopes of increasing their overall physical activity levels.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receiving the Exercise is Medicine program along with a smartwatch.
Behavioral: EIM+
The Exercise is Medicine (EIM) program involves a personalized exercise prescription and wellness coaching component. At the first 1:1 session, participants are provided with a Fitbit and onboarded with Fitabase, allowing for documentation of baseline health behaviors. Over the course of the program, the EIM fitness specialist reviews Fitbit data and progress towards goals, sending push notifications for encouragement and reminders. A personal training session is conducted, followed by sixteen group sessions including up to eight participants. The final session includes updating goals, incorporating Fitbits, and providing an updated exercise prescription. Upon program completion, participants will attend monthly webinars and health coaching sessions at 6- and 12-months post-program. The program aims to help individuals overcome barriers and maintain long-term exercise self-efficacy.
Feasibility of EIM+
The co-primary outcome is to determine the feasibility of utilizing smartwatches among Exercise is Medicine participants aged 65+ as assessed by the number of eligible referrals agreeing to participate in the intervention, program attendance, and completion rates.
Time frame: 12 months
Acceptability of EIM+
The co-primary outcome is to determine the acceptability of utilizing smartwatches among Exercise is Medicine (EIM) participants aged 65+ as assessed by survey responses on perception of wearable devices integrated in to the EIM program and program attendance and completion rates.
Time frame: 12 months
Change in physical activity
The secondary outcome of physical activity levels before, during and after program completion (preliminary efficacy) will be examined both continuously (moderate-vigorous physical activity minutes per week) and categorically (meeting the goal of 150 minutes of moderate-vigorous physical activity per week).
Time frame: 12 months
Change in weight
The secondary outcome is weight before, during and after program completion
Time frame: 12 months
Change in BMI
The secondary outcome is BMI before, during and after program completion
Time frame: 12 months
Change in hip circumference
The secondary outcome is hip circumference before, during and after program completion
Time frame: 12 months
Change in waist circumference
The secondary outcome is waist circumference before, during and after program completion
Time frame: 12 months
Change in blood pressure
The secondary outcome is blood pressure before, during and after program completion
Time frame: 12 months
Change in heart rate variability
The secondary outcome is heart rate variability before, during and after program completion
Time frame: 12 months
Change in hemoglobin A1c
The secondary outcome is hemoglobin A1c before, during and after program completion
Time frame: 12 months
Change in perceived stress
The secondary outcome is perceived stress before, during and after program completion as assessed by responses to the Perceived Stress Scale assessment.
Time frame: 12 months
Change in depressive symptoms
The secondary outcome is depressive symptoms before, during and after program completion as assessed by responses to the Patient Health Questionnaire-9 (PHQ-9)
Time frame: 12 months
Change in diet
The secondary outcome is diet before, during and after program completion as assessed by responses to the Mediterranean Eating Pattern for Americans diet adherence screener.
Time frame: 12 months
Change in activity minutes per week
The secondary outcome is activity minutes per week before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in daily steps total
The secondary outcome is daily steps taken before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in measured steps per minute
The secondary outcome is measured steps per minute before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in sleep quality
The secondary outcome is sleep quality before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in sleep duration
The secondary outcome is sleep duration before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in estimated energy expenditure
The secondary outcome is estimated energy expenditure before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in heart rate
The secondary outcome is heart rate before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in distance moved
The secondary outcome is distance moved before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in minutes of vigorous activity
The secondary outcome is minutes of vigorous activity before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in minutes of moderate activity
The secondary outcome is minutes of moderate activity before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in minutes of light activity
The secondary outcome is minutes of light activity before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in minutes of sedentary time
The secondary outcome is minutes of sedentary time before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in number of manually entered and automatically detected physical activities (walking, running, etc.)
The secondary outcome is manually entered and automatically detected physical activities (walking, running, etc.) before, during and after program completion as assessed by smartwatch tracking.
Time frame: 12 months
Change in quality of life measures
The secondary outcome is quality of life measures before, during and after program completion as assessed by responses to the RAND Short Form (RAND-SF 36) v1.0 survey.
Time frame: 12 months
Plan to share: No
Ran from Mar 2024 to primary completion in Apr 2026, 24 months.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's 24 months is above that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion May 2026 → Apr 2026 and completion May 2026 → Apr 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.